Last updated: February 25, 2026
What is the product associated with NDC 29300-0155?
NDC 29300-0155 corresponds to Lidocaine Hydrochloride Injection, 20 mg/mL. It is used primarily for local anesthesia during medical procedures.
What is the current market size for Lidocaine injections?
The global local anesthetics market was valued at approximately $2.6 billion in 2021. It is projected to reach $3.7 billion by 2028, growing at a CAGR of 5.0% (Fortune Business Insights, 2022). Residential and institutional medical use accounts for around 70% of this market, with hospitals and outpatient surgical centers as primary consumers.
Within this, the U.S. accounts for approximately 40% of sales. The U.S. market for lidocaine injections alone was estimated at $1.0 billion in 2022, primarily driven by elective procedures and general anesthesia needs.
Who are the key players in the lidocaine injection market?
Major manufacturers include:
- Hospira (a Pfizer company)
- Becton Dickinson
- Teva Pharmaceuticals
- Sagent Pharmaceuticals
- Hikma Pharmaceuticals
Their product portfolios include both branded and generic lidocaine injections, with price points varying by formulation, container size, and regulatory status.
How is pricing structured currently?
Prices for generic lidocaine hydrochloride injections range from:
| Container Size |
Price Range (USD) |
Approximate Cost per mL |
| 50 mL vial |
$15 - $25 |
$0.30 - $0.50 |
| 100 mL vial |
$25 - $40 |
$0.25 - $0.40 |
| Ampules (10 mL) |
$5 - $10 per unit |
$0.50 - $1.00 |
Branded formulations, although less common, can be priced 2-3 times higher.
What are the factors shaping future price trends?
- Generic competition: Entry of additional generic manufacturers suppresses prices.
- Regulatory changes: FDA policies favoring price transparency and quality assurance could exert downward pressure.
- Supply chain dynamics: Raw material costs, notably for local anesthetics, can influence manufacturing costs.
- Market demand: Growth in outpatient procedures and minimally invasive surgery increases demand.
What are projected prices for the next five years?
Assuming continued generic penetration and stable raw material costs:
| Year |
Median Price per 50 mL vial |
Price Change (YoY) |
| 2023 |
$17 |
-2% to -4% |
| 2024 |
$16.50 |
-2% |
| 2025 |
$16 |
-2% |
| 2026 |
$15.50 |
-2.5% |
| 2027 |
$15 |
-3% |
Prices are expected to decline gradually owing to increased competition, with potential stabilization if supply chain disruptions or regulatory constraints emerge.
What regulatory changes could impact pricing?
- Increased fibrosity with biosimilars or alternative local anesthetics might force price adjustments.
- Policies promoting price transparency could pressure manufacturers to reduce markups.
- The potential reclassification of compounded anesthetics might influence hospital procurement strategies.
Summary of key points
- The U.S. lidocaine injection market exceeds $1 billion annually.
- Price for generic formulations hovers around $0.25-$0.50 per mL.
- Competition and regulatory policies are primary drivers for forecasted slight price declines.
- Market growth aligns with rising demand for outpatient and minimally invasive procedures.
- Vendor consolidation or patent challenges are unlikely; competition will stay the dominant influence.
Key Takeaways
- The lidocaine injection market’s future pricing depends on generic entry, raw material costs, and regulatory environment.
- Prices are expected to decline marginally over the next five years.
- The U.S. remains the primary growth driver, with hospital and outpatient procedure volumes rising.
- Suppliers that innovate on formulation or delivery systems could command higher premiums.
- Market stability depends on supply chain resilience and regulatory consistency.
FAQs
1. Will new formulations impact the price of NDC 29300-0155?
Potentially. Novel delivery systems or sustained-release versions may command premium pricing, but standard formulation prices will likely trend downward due to competition.
2. How vulnerable is this market to regulatory changes?
Moderately. Heavy regulation ensures safety but can introduce barriers to new entrants. Policy changes favoring transparency might lower prices.
3. Is there significant demand outside the U.S.?
Yes. Emerging markets exhibit increasing adoption of local anesthetics, though pricing is often lower due to market competition.
4. Could biosimilars influence prices?
Biosimilars are not directly relevant for small molecules like lidocaine but might influence overarching anesthetic market dynamics.
5. What are the main risks to forecasted price declines?
Supply chain disruptions, raw material cost spikes, or regulatory shifts that restrict generic competition could limit price reductions.
Sources
[1] Fortune Business Insights. (2022). Global local anesthetics market size, share & industry analysis.
[2] IQVIA. (2022). Pharmaceutical Market Reports.
[3] U.S. Food & Drug Administration. (2022). Regulatory updates on generic drugs.
[4] MedlinePlus. (2022). Lidocaine injection information.
